Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6391-6397

  Chiang, S L ^a   Mekalanos, J J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLERA VACCINE; RECOMBINASE;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CHOLERA; DIARRHEA; DRUG DESIGN; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSPOSON; VIBRIO CHOLERAE;

ANIMAL; BACTERIAL PROTEINS; CHLORAMPHENICOL; CHOLERA VACCINES; DNA NUCLEOTIDYLTRANSFERASES; DNA TRANSPOSABLE ELEMENTS; GENETIC COMPLEMENTATION TEST; MICE; SUPPORT, U.S. GOV'T, P.H.S.; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 0033791981     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6391-6397.2000     Document Type: Article

References (66)

1. Phenotypic and genotypic characterization of Vibrio cholerae isolates from a recent cholera outbreak in Senegal: Comparison with isolates from Guinea-Bissau
2. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh
3. History of cholera
4. Cholera: Pathophysiology, clinical features, and treatment
5. Heterologous antigen expression in Vibrio cholerae vector strains
6. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum
7. Gene disruption in Escherichia coli: Tc(R) and Km(R) cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant
8. Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance
9. Microbiological and epidemiological investigation of cholera epidemic in Ukraine during 1994 and 1995
10. Field trial of oral cholera vaccines in Bangladesh
11. Field trial of oral cholera vaccines in Bangladesh: Results from three-year follow-up
12. Safety, immunogenicity and efficacy of a live attenuated Vibrio cholerae O139 vaccine protype, Bengal-15
13. The FLP protein of the yeast 2mm plasmid: Expression of a eukaryotic genetic recombination system in Escherichia coli
14. FLP site-specific recombination system of Saccharomyces cerevisiae
15. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand, are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes
16. Molecular evolution of Vibrio cholerae O1 strains isolated in Lima, Peru, from 1991 to 1995
17. Transposition of the mariner element from Drosophila mauritiana in zebrafish
18. The epidemiology of cholera
19. Vibrio cholerae and cholera
20. Trans-kingdom transposition of the Drosophila element mariner within the protozoan Leishmania
21. Epidemiological study of Vibrio cholerae O1 and O139 in Thailand: At the advancing edge of the eighth pandemic
22. Protective oral cholera vaccine based on a combination of cholera toxin B subunit and inactivated cholera vibrios
23. Cholera and the immune response
24. Convenient and reversible site-specific targeting of exogenous DNA into a bacterial chromosome by use of the FLP recombinase: The FLIRT system
25. Changes in Vibrio cholerae O1 strains isolated in Romania during 1977-95
26. Vibdo cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences
27. TnAraOut, a transposon-based approach to identify and characterize essential bacterial genes
28. Toxins of Vibrio cholerae
29. Cholera
30. Typing and antibiotic susceptibility patterns of Vibrio cholerae during six consecutive cholera seasons in north India
31. Isolation and identification of Vibrio cholerae O1 from fecal specimens
32. Peru-15, an improved live, attenuated oral vaccine candidate for Vibrio cholerae O1
33. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques
34. Immunity and vaccine development
35. The transposable element mariner mediates germline transformation in Drosophila melanogaster
36. Gene transfer into the medfly, Ceratitis capitata, with a Drosophila hydei transposable element
37. Germline transformation of Drosophila virilis mediated by the transposable element hobo
38. Flagella and motility
39. Clinical management of cholera
40. Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching
41. A novel suicide vector and its use in construction of insertion mutations: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR
42. Transmission of Vibrio cholerae O1
43. The 1968-1969 cholera vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests
44. Cholera in children in Karachi from 1990 through 1995: A study of cases admitted to a tertiary care hospital
45. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response
46. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory
47. Investigation of the outbreak of cholera in Alleppey and Palghat districts, south India
48. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India
49. Transposition of the nematode Caenorhabditis elegans Tc3 element in the zebrafish Danio rerio
50. Cholera in Piura, Peru: A modern urban epidemic
51. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria
52. Bacteriology of Vibrio and related organisms
53. Conjugative transposition
54. Serotype conversion in Vibrio cholerae O1
55. Immunity to Vibrio cholerae infection
56. Waterborne transmission of epidemic cholera in Trujillo, Peru: Lessons for a continent at risk
57. Safety, immunogenicity, and transmissibility of live oral cholera vaccine candidate CVD112, a DctxA Dzot Dace derivative of El Tor Ogawa Vibrio cholerae
58. The Latin American epidemic
59. Development of a live, oral, attenuated vaccine against El Tor cholera
60. Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama
61. Epidemic cholera in Trujillo, Peru, 1992: Utility of a clinical case definition and shift in Vibrio cholerae O1 serotype
62. The molecular epidemiology of cholera in Latin America
63. The Vibrio cholerae O139 serogroup antigen includes O-antigen capsule and lipopolysaccharide virulence determinants
64. Cholera in 1997
65. The Himar1 mariner transposase cloned in a recombinant adenovirus vector is functional in mammalian cells